Navigation Links
CareFusion To Acquire Vital Signs Division of GE Healthcare For $500 Million
Date:11/18/2013

ies by Dec. 31, 2013, and to finalize the remainder of the transaction during its third quarter, ending March 31, 2014, subject to regulatory review and customary closing conditions.

Upon completion of the transaction, Vital Signs will be CareFusion's eighth acquisition since 2010.

Headquartered in Totowa, New Jersey, Vital Signs has more than 1,000 employees in three primary locations worldwide, including manufacturing operations in Shenzhen, China, and a global, field-based sales organization.

Conference Call

CareFusion will host a webcast and conference call today at 6 a.m. PST (9 a.m. EST) to discuss the acquisition.

To access the call, visit the Investors page at www.carefusion.com. Log on at least 15 minutes before the call begins to register and download or install any necessary audio software.

Investors and other interested parties may also access the call by dialing 877.415.3178 within the U.S. or 857.244.7321 from outside the U.S. and using the access code 87173662. A replay of the conference call will be available from 10 a.m. PST (1 p.m. EST) on Nov. 18 through 11:59 p.m. PST on Nov. 25 and can be accessed by dialing 888.286.8010 in the U.S. or 617.801.6888 from outside the U.S. and using the access code 38703278.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps,

SOURCE CareFusion Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CareFusion Highlights Patient Safety, Actionable Data, Emergency Preparedness at American Association for Respiratory Care Congress
2. CareFusion Reports First Quarter Fiscal 2014 Results
3. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
4. CareFusion Reports Fourth Quarter And Fiscal 2013 Results
5. Early Morning Insight: Baxter, CareFusion, Unilife, and Mindray Medical
6. FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard
7. CareFusion To Report Fourth Quarter And Fiscal 2013 Results On Aug. 8
8. 14 Additional Hospitals Select CareFusion Pyxis ES Platform To Improve Medication Management Efficiency, Safety
9. MD Anderson Signs Contract For Pyxis ES Technology From CareFusion
10. CareFusion Reports Third Quarter Fiscal 2013 Results
11. CareFusion Reaches Agreement In Principle On Previously Disclosed Matter With Federal Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Israele, February 27, 2015 ... nel suo sviluppo dell,innovativo sistema di monitoraggio dell,infarto ... primo trial sull,uomo-     ... nello sviluppo di nuovo sistema per il monitoraggio ... (CHF), ha annunciato oggi di aver concluso una ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... , Feb. 27, 2015 An aggressive campaign ... cut the rate of infection with a dangerous drug-resistant ... Clostridium difficile, or C.diff, is a bacterium ... inflammation of the colon. A recent article in the ... difficile Infection in the United States ...
Breaking Medicine Technology:Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3
... , LOS ANGELES, Aug. 7 A new ... any drug and sealed to the outer surface (episclera) of the ... of medicines for retinal and vitreous diseases, according to a new ... in The Vision Center at Children,s Hospital Los Angeles. Dr. Murphree ...
... , , CARLSBAD, Calif., Aug. ... its financial results for the quarter ended June 30, 2009. During ... a result reported $669,000 of pro forma net income for the quarter ... 2008. Isis also reported a pro forma net operating loss of $1.3 ...
Cached Medicine Technology:Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 2Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 3Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases 4Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 2Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 3Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 4Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 5Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 6Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 7Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 8Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 9Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 10Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 11Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 12Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 13Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 14Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 15Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 16Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 17Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 18Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 19Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 20Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 21Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009 22
(Date:2/28/2015)... February 28, 2015 In a recent ... of Game Change Athlete Development Services ... about the benefits of athlete development and player engagement ... the unique challenges that athletes face and how off-field ... success. , Fletcher became involved in athlete development issues ...
(Date:2/28/2015)... The Heart Fit Clinic started doing External Counterpulsation ... The Heart Fit Clinic is also selling the machines ... The goal is to scale the business to help ... buy External Counterpulsation machines can be difficult process. ... process and achieve the desired results. , The ...
(Date:2/28/2015)... February 28, 2015 Mew and Company, ... that they now provide business consulting services in addition ... corporate tax planning and succession planning. Company finances are ... experienced professionals. On top of this, complex Canadian tax ... corporate accounting. As a result, Mew and Company works ...
(Date:2/28/2015)... A study out of the University of Oxford ... the treatment of a hereditary ocular condition that leads ... Dr. Robert MacLaren, professor of ophthalmology at the University ... on January 16, 2014 , the study treated six ... mostly affects men and leads to the degeneration of ...
(Date:2/28/2015)... OR (PRWEB) February 28, 2015 Pioneer ... the 2015 Japan Architecture & Construction Materials Show, an ... join more than 1,000 suppliers and top manufacturers of ... Reclaimed wood products sourced and manufactured by ... have found popularity in Japan at restaurants, hotels, retailers, ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2
... developed for preventing and treating the flue have shown ... dose to be effective.// The compounds, known collectively as ... relenza, or zanamivir, which the U.S. Food and Drug ... B. ,Researchers reported at the International Conference on ...
... to be worrisome threats, common pest control agent called ... treatments in eradicating deadly bacterial spores from buildings. Tests ... 50 years to control insect pests in buildings, grain ... than current treatments such as chlorine dioxide for killing ...
... giant GlaxoSmithKline (GSK), under fire regarding its smoking cessation drug, ... - in the wake of unproven reports in the UK, ... , ,Touted to be the world’s most successful smoking cessation ... June 2001. The cause for concern, however, was a safety ...
... University Hospital, a common cholesterol fighting drug, a statin ... heart complications by up to 20 percent for about ... heart events -- such as dying of heart disease ... Dr. Patrick Serruys,// professor of interventional cardiology at Erasmus ...
... the Marquette University School of Dentistry suggest chronic periodontal ... diabetes.//The research ties the incidence of diabetes in patients ... the bloodstream that triggers a reaction from the immune ... release proteins called cytokines that can disrupt production of ...
... University of Texas in US have found that African American ... women.// Ovarian cancer causes more deaths than any other cancer ... ethnicity is an independent risk factor in prognosis. US researchers ... 600 African American women with ovarian cancer. They find that ...
Cached Medicine News:Health News:Cholesterol Drug Helps After Angioplasty 2Health News:Cholesterol Drug Helps After Angioplasty 3
... heart surgery is no longer the only ... in young children and in patients with ... are seeking non-surgical options to close inter-atrial ... a permanently implanted prosthesis and catheter delivery ...
... The National Laboratory Training Network (NLTN) ... Association of Public Health Laboratories (APHL) and ... (CDC). NLTN provides cost-effective training in a ... resources, including a FREE Lending Library. Log ...
... Testing and Quality Assurance (for Waived and ... POLs, clinics and small hospitals maintain laboratory ... of patient lab results and assist labs ... opportunity to earn 12 P.A.C.E. Contact hours ...
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
Medicine Products: